Prevention | Alzheimer's Prevention Registry

You are here


The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s- Focused Studies

Recruitment for Alzheimer’s disease (AD) focused studies, particularly prevention studies, is challenging due to the public’s lack of awareness about study opportunities coupled with studies’ inclusion and exclusion criteria, resulting in a high screen fail rate. 

Digital devices and artificial intelligence partner to measure early brain changes

Smartphones and smartwatches already measure our heart rate, sleep patterns and oxygen levels. These and other so-called digital biomarkers coupled with artificial intelligence could one day soon identify early memory and thinking changes to help us optimize our brain health.

Study explores whether computerized brain training can prevent dementia

A new, NIH-funded, multi-site study is exploring whether computerized brain training can prevent dementia. Preventing Alzheimer’s with Cognitive Training (PACT) will examine whether a specific type of computerized training can reduce the risk of dementia such as Alzheimer’s disease for adults over 65.  

New study uses tailored dosing approach that aims to help prevent Alzheimer’s

A new Alzheimer’s clinical trial is recruiting people as young as 55 to participate in a study of an anti-amyloid investigational therapy. The study is groundbreaking because the study medication doses are tailored based on each participant’s level of brain amyloid. Read more about how the AHEAD Study aims to get ahead of Alzheimer’s before symptoms appear. 

First treatment in two decades approved for Alzheimer’s

The FDA approved the first new treatment for Alzheimer’s disease in almost two decades on June 7. Aducanumab is also the first approved drug to change the course of the disease by removing brain plaques, a signature of Alzheimer’s. But mixed results on its ability to slow the decline of memory and thinking skills caused some researchers to question the effectiveness of the novel treatment.

Discrimination and bias found in dementia care

The Alzheimer’s Association surveyed Black, Hispanic, Asian and Native Americans about their access to Alzheimer’s and dementia care. The results, which are reported in the 2021 Facts and Figures Report, show discrimination is a barrier to care for many minority groups. The report shares statistics from the survey and recommendations to combat discrimination in dementia care.

COVID-19 infection can harm the brain

Researchers are finding COVID-19 can significantly impact the brain. From neurological symptoms to mental well-being, the virus is taking a toll on the brain. In a new report the Global Council on Brain Health offers recommendations to safeguard your brain health during the pandemic.

Vaccines, gene therapy and other novel approaches to future Alzheimer’s treatments

Alzheimer’s researchers are seeking new ways to prevent and treat Alzheimer’s disease. Could novel treatments such as vaccines and gene therapy hold the key to a new type of treatment? Researchers are delving into that question.

Research shows intermittent fasting may prevent Alzheimer’s disease

Intermittent fasting is a popular option for weight loss. Scientists are now learning it may also be able to improve memory and thinking. Read more about potential option for delaying Alzheimer’s disease.

Asian Americans and Pacific Islanders have a new way to participate in Alzheimer’s studies

Minority groups have long been underrepresented to medical research, including studies for Alzheimer’s and related dementias. A new registry aims to change that. The CARE registry is enrolling Asian Americans and Pacific Islanders to connect them to research in memory and thinking problems, aging and caregiving.